Jaundice: Clinical Trials

21 trials for Jaundice, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 unknown, 3 recruiting, 1 active not recruiting. 21 Phase 2, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 221Completed 11, Unknown 4, Recruiting 3, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 14Active not recruiting 1, Completed 1, Terminated 1, Unknown 1
Phase 32Completed 1, Unknown 1

Follow Jaundice: new trials by email Literature Review of Jaundice trials Research Report on Jaundice

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY
Zinc sulfate, Probiotic lactobacillus rhamnosus GG - Indirect Hyperbilirubinemia, Neonatal
Phase 2RecruitingQuaid-e-Azam Medical College1102025-08-072025-08-05
COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
The COMBO Endoscopy Oropharyngeal Airway - Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice
Phase 2RecruitingZhejiang University502025-06-122025-06-24
Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study
Supraglottic Oxygen Delivery via an Endotracheal Tube - Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice
Phase 2RecruitingZhejiang University502025-06-122025-07-17
Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice
Pentoxifylline - Hepatobiliary Disorders
Phase 2CompletedTanta University452025-04-302026-09-30
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
RTX001 - End-stage Liver Disease (ESLD), Cirrhosis, Liver
Phase 1 / Phase 2Active not recruitingResolution Therapeutics Limited302024-10-152026-10-05
Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice
N-acetylcysteine - Hepatic and Post Hepatic Jaundice
Phase 2CompletedTanta University442024-02-142026-07-22
Needle-Knife Fistulotomy Vs. Standard Cannulation Trial
Needle Knife Fistulotomy, standard biliary cannulation - Biliary Obstruction Due to Common Bile Duct Stone, Malignant Bile Duct Obstruction
Phase 1 / Phase 2CompletedThomas Jefferson University1862019-01-312024-11-19
Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)
Selonsertib, Prednisolone, Placebo - Alcoholic Hepatitis (AH)
Phase 2CompletedGilead Sciences1042016-09-012019-02-06
The Effects of Dexamethasone Administration on Jaundice Following Liver Resection
Dexamethasone - Liver Dysfunction, Hepatectomy
Phase 2 / Phase 3CompletedShanghai Zhongshan Hospital762016-06-012021-06-10
SMOFlipid to Lessen the Severity of Neonatal Cholestasis
SMOFlipid - Cholestasis, Jaundice, Obstructive
Phase 1 / Phase 2TerminatedUniversity of Florida22016-05-012017-04-17
Radiofrequency Ablation for Biliopancreatic Malignancy
Radiofrequency ablation (StarMed) - Pancreas Cancer, Cholangiocarcinoma
Phase 2CompletedUniversitaire Ziekenhuizen KU Leuven182014-11-012016-05-11
Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.
neostigmine methylsulfate,raceanisodamine hydrochloride - Systemic Inflammatory Response Syndrome, Jaundice, Obstructive
Phase 1 / Phase 2UnknownWanqing Gu1002014-08-012014-10-30
Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
bilateral metal stent insertion, unilateral metal stent insertion - Hilar Cholangiocarcinoma
Phase 2 / Phase 3UnknownAir Force Military Medical University, China702014-07-012019-08-01
Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy
Pancreatoduodenectomy, ENBD and Pancreatoduodenectomy, EBD and Pancreatoduodenectomy - Pancreatic Cancer, Periampullary Carcinoma
Phase 2UnknownSouthwest Hospital, China2742014-01-012014-01-14
The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice
Ursodeoxycholic Acid - Obstructive Jaundice
Phase 2UnknownUniversity Clinical Centre of Kosova542012-12-012012-10-02
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Low Dose Lovastatin, Placebo, High Dose Lovastatin - Stroke, Rhabdomyolysis
Phase 2CompletedColumbia University1622009-02-012025-12-01
Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of Infants
Early Cord Clamping, Delayed Cord Clamping - Anemia, Ferritin
Phase 2CompletedAga Khan University3402008-08-012012-08-02
Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer
surgery, endoscopic strategy - Pancreatic Neoplasms, Biliary Tract Neoplasms
Phase 2WithdrawnKarolinska Institutet2007-03-012013-04-12
Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors.
Plastic stent (7-10Fr), Self Expanding Metal Stent - Obstructive Jaundice, Periampullary Tumour
Phase 2CompletedKarolinska University Hospital922007-03-012015-10-22
Safety and Pharmacology of Stanate
Stanate - Hyperbilirubinemia
Phase 2CompletedInfaCare Pharmaceuticals Corporation, a Mallinckrodt Company552005-09-012019-10-15

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Jaundice, Obstructive (8)  ·  Pancreatic Neoplasms (4)  ·  Cholangiocarcinoma (2)  ·  Cholelithiasis (2)  ·  Cholestasis (2)  ·  Fibrosis (2)  ·  Hyperbilirubinemia (2)  ·  Hypoxia (2)  ·  Liver Diseases (2)  ·  Pancreatitis (2)  ·  Respiratory Insufficiency (2)  ·  Anemia (1)  ·  Anemia, Neonatal (1)  ·  Biliary Tract Neoplasms (1)

Broader conditions

Pathologic Processes (21)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Signs and Symptoms (21)  ·  Skin Manifestations (21)  ·  Hyperbilirubinemia (19)  ·  Digestive System Diseases (11)  ·  Pancreatic Diseases (6)  ·  Biliary Tract Diseases (5)  ·  Digestive System Neoplasms (4)  ·  Endocrine Gland Neoplasms (4)  ·  Endocrine System Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Adenocarcinoma (2)

Interventions

Acetylcysteine (1)  ·  Dexamethasone (1)  ·  Ferritins (1)  ·  Lovastatin (1)  ·  Pancreaticoduodenectomy (1)  ·  Parenteral Nutrition (1)  ·  Pentoxifylline (1)  ·  Prednisolone (1)  ·  Probiotics (1)  ·  Radiofrequency Ablation (1)  ·  SMOFlipid (1)  ·  Surgical Procedures, Operative (1)  ·  Umbilical Cord Clamping (1)  ·  Ursodeoxycholic Acid (1)  ·  Zinc (1)

Sponsors

Tanta University (2)  ·  Zhejiang University (2)  ·  Aga Khan University (1)  ·  Air Force Military Medical University, China (1)  ·  Cancer Advances Inc. (1)  ·  Columbia University (1)  ·  Gilead Sciences (1)  ·  InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (1)  ·  Karolinska Institutet (1)  ·  Karolinska University Hospital (1)  ·  Quaid-e-Azam Medical College (1)  ·  Resolution Therapeutics Limited (1)  ·  Shanghai Zhongshan Hospital (1)  ·  Southwest Hospital, China (1)  ·  Thomas Jefferson University (1)

Countries

China (6)  ·  United States (4)  ·  Belgium (2)  ·  Egypt (2)  ·  Pakistan (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Canada (1)  ·  France (1)  ·  Serbia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Vietnam (1)

Top investigators

Dr Huma Shaireen, MBBS, FCPS (1)  ·  Dr Zulfiqar Bhutta, MBBS, PhD (1)  ·  Enver H Fekaj, PhD student (1)  ·  Farshad Frozanpor (1)  ·  Guohong Han, MD,Ph.D (1)  ·  Huai-zhi Wang, M.D., Ph.D. (1)  ·  Hui-Chuan Sun, MD (1)  ·  Josef Neu, MD (1)  ·  Laleman Wim, MD PhD (1)  ·  Lars Lundell, Professor (1)  ·  Malik M. Umair Fazal, MBBS, FCPS Paediatrics (1)  ·  Mitchell S Elkind, MD, MS (1)  ·  Samah Hussein (1)

Results publications

PMID 11231856, PMID 20940288, PMID 24053627, PMID 24224656, PMID 26176387, PMID 28732391

NIH funding

2016 (1), P50NS049060 (1)